Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Class II Vaccine	1.22B
Class II Vaccine Growth	-1.30%
Class I Vaccine	152.00M
Class I Vaccine Growth	88.96%
Research and Development Services	25.57M

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.